Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Blood Cancer Discovery
|
October 18, 2021
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Research Square
|
June 17, 2024
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma
Malin Hultcrantz, Hani Hassoun, Neha Korde, et al.
Blood Cancer Discovery
|
October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
The Lancet. Haematology
|
May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Benjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 15, 2022
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
Kenneth Cornetta, Jing Yao, Kimberley House, et al.
Blood Cancer Journal
|
September 19, 2024
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
Malin Hultcrantz, Hani Hassoun, Neha Korde, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
American Journal of Hematology
|
April 26, 2022
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
Meera Mohan, Melody Renee Becnel, Urvi A Shah, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Blood Cancer Discovery
|
October 18, 2021
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Research Square
|
June 17, 2024
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma
Malin Hultcrantz, Hani Hassoun, Neha Korde, et al.
Blood Cancer Discovery
|
October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
The Lancet. Haematology
|
May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Benjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 15, 2022
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
Kenneth Cornetta, Jing Yao, Kimberley House, et al.
Blood Cancer Journal
|
September 19, 2024
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
Malin Hultcrantz, Hani Hassoun, Neha Korde, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
American Journal of Hematology
|
April 26, 2022
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
Meera Mohan, Melody Renee Becnel, Urvi A Shah, et al.
Page
of 18